[Preliminary study on the use of the cytostatic drug E 39 in the therapy of prostate carcinoma].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D054697:Cytostatic Agents; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms; D011809:Quinones / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D054697:Cytostatic Agents; D011809:Quinones
CYTOTOXIC DRUGS/therapeutic use; PROSTATE/neoplasms; QUINONES/therapeutic use
Studio preliminare sull'impiego del citostatico E 39 nella terapia del carcinoma prostatico.